Evidence map›Paper›PMID 30173215›Full record

ReviewMedical principles and practice : international journal of the Kuwait University, Health Science Centre2018

Rheumatoid Arthritis: A Brief Overview of the Treatment.

Jacqueline Bullock, Syed A A Rizvi, Ayman M Saleh, Sultan S Ahmed, Duc P Do, Rais A Ansari, Jasmin Ahmed

Open access · diamondAbstract readReview
In one paragraph

Review in Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 308 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
308citing papers in PubMed, 7 pooled it
21.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

308 citing papers in PubMed, 7 syntheses or guidelines pooled it, 743 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Efficacy and Mechanisms ofCurrent rheumatology reviews · 2024
    Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

248 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Jacqueline BullockKeiser University, Fort Lauderdale, Florida, USA.
Syed A A RizviSchool of Pharmacy, Hampton University, Hampton, Virginia, USA.
Ayman M SalehKing Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center (KAIMRC), Jeddah, Saudi Arabiaayman.saleh09@gmail.com.
Sultan S AhmedNova Southeastern University, Fort Lauderdale, Florida, USA.
Duc P DoUniversity of Georgia, Athens, Georgia, USA.
Rais A AnsariNova Southeastern University, Fort Lauderdale, Florida, USA.
Jasmin AhmedLarkin Community Hospital, Miami, Florida, USA.
Nova Southeastern University · USHampton University · USKeiser University · USKing Abdullah International Medical Research Center · SALarkin Community Hospital · USUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disease, affecting the joints with varying severity among patients. The risk factors include age, gender, genetics, and environmental exposure (cigarette smoking, air pollutants, and occupational). Many complications can follow, such as permanent joint damage requiring arthroplasty, rheumatoid vasculitis, and Felty syndrome requiring splenectomy if it remains unaddressed. As there is no cure for RA, the treatment goals are to reduce the pain and stop/slow further damage. Here, we present a brief summary of various past and present treatment modalities to address the complications associated with RA.

Indexed as

Adrenal Cortex HormonesAnalgesics, OpioidAntibodies, Monoclonal, HumanizedAnti-Inflammatory Agents, Non-SteroidalAntirheumatic AgentsArthritis, RheumatoidHumansImmunosuppressive AgentsInterleukin 1 Receptor Antagonist ProteinLeflunomidePhysical Therapy ModalitiesRisk FactorsTumor Necrosis Factor-alphaAdrenal Cortex HormonesAnalgesics, OpioidAntibodies, Monoclonal, HumanizedAnti-Inflammatory Agents, Non-SteroidalAntirheumatic AgentsImmunosuppressive AgentsInterleukin 1 Receptor Antagonist ProteinLeflunomidetocilizumabTumor Necrosis Factor-alphaBoutonnière deformityRheumatoid arthritisSwan neck deformity

Identifiers

PMID30173215
PMCPMC6422329
OpenAlexW2890017737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.